BelHealth Investment Partners has appointed Burt Zweigenhaft as an operating partner. Prior to joining BelHealth, Zweigenhaft worked at Onco360 where he served as the founder, CEO and vice chairman.
New York, NY – August 28, 2015 – BelHealth Investment Partners (“BelHealth”), a healthcare-focused private equity firm, announced that Burt Zweigenhaft has joined the firm as an Operating Partner and Board member of Linden Care and Apothecary by Design.
Mr. Zweigenhaft has 30 years of experience in the specialty-biotech pharmaceutical and oncology cancer care ecosystem. Previously, Mr. Zweigenhaft was the Founder, CEO and Vice Chairman of Onco360, a national oncology pharmacy care management provider. In 2014, PharMerica acquired controlling interest in Onco360. Mr. Zweigenhaft previously served as Senior Vice President of Managed Care Sales and Marketing, Government Programs, Trade Relations and Business Development Strategies for Priority Healthcare, a publicly traded company in the specialty pharmacy sector with $2.3 billion in specialty drug revenues before being acquired by Express Scripts in 2005. Before joining Priority Healthcare, Mr. Zweigenhaft spent several years serving as a specialty pharmacy consultant to Medco, CuraScript, BioScrip and several Regional National Blue Cross Blue Shield and National Managed Care Payer programs.
Mr. Zweigenhaft is a member of AMCP (American Managed Care Pharmacy), HOPA (Hematology Oncology Pharmacists Association) and ASCO (American Society of Consulting Oncologists). Mr. Zweigenhaft also serves on the Editorial Boards of several industry publications and is Editor and Chief of the Journal for Value Based Cancer Care. Mr. Zweigenhaft is also Co-Chairman and Co-Founder of the Association for Value Based Cancer Care and serves as a Board Member of and Vice President of NASP (National Association of Specialty Pharmacy) in Washington, DC.
Dennis Drislane, BelHealth Managing Partner, stated, “We are excited to welcome Burt to our team as an Operating Partner and Board member of Linden Care and Apothecary by Design. Burt’s knowledge and experience across the healthcare services landscape will be invaluable to BelHealth as we invest our second fund. Similar to the leadership of BelHealth, Burt is an experienced, hands-on operator that understands the challenges lower middle market healthcare businesses face. We are pleased to add an entrepreneur of Burt’s caliber to our team. We look forward to his contributions in sourcing new investment opportunities, helping find exceptional executives and working with our portfolio companies to accelerate their growth.”
About BelHealth Investment Partners
BelHealth Investment Partners (“BelHealth”), based in New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth has a unique combination of investing, executive management and entrepreneurial experience. BelHealth acquires majority positions in entrepreneur-owned companies that it believes would benefit from its extensive operating and private equity investment expertise. The firm typically invests $20-50 million per platform company across three healthcare segments: Services, Products and Distribution.
For further information, please visit: BelHealth Investment Partners: www.belhealth.com